PT1197207E - Composições estáveis para administração parentérica - Google Patents

Composições estáveis para administração parentérica

Info

Publication number
PT1197207E
PT1197207E PT01308284T PT01308284T PT1197207E PT 1197207 E PT1197207 E PT 1197207E PT 01308284 T PT01308284 T PT 01308284T PT 01308284 T PT01308284 T PT 01308284T PT 1197207 E PT1197207 E PT 1197207E
Authority
PT
Portugal
Prior art keywords
compounds
parenteral administration
lambda
warm
alpha
Prior art date
Application number
PT01308284T
Other languages
English (en)
Inventor
William David Steber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT1197207E publication Critical patent/PT1197207E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT01308284T 2000-10-10 2001-09-28 Composições estáveis para administração parentérica PT1197207E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23892500P 2000-10-10 2000-10-10

Publications (1)

Publication Number Publication Date
PT1197207E true PT1197207E (pt) 2008-07-01

Family

ID=22899893

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01308284T PT1197207E (pt) 2000-10-10 2001-09-28 Composições estáveis para administração parentérica

Country Status (9)

Country Link
EP (1) EP1197207B1 (pt)
JP (1) JP4221170B2 (pt)
AT (1) ATE392887T1 (pt)
CA (1) CA2358361C (pt)
CY (1) CY1108145T1 (pt)
DE (1) DE60133706T2 (pt)
DK (1) DK1197207T3 (pt)
ES (1) ES2304371T3 (pt)
PT (1) PT1197207E (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852843B1 (fr) 2003-03-24 2008-05-23 Karim Ioualalen Systeme galenique permettant le masquage du gout
FR2913884A1 (fr) * 2007-03-21 2008-09-26 Oralance Pharma Sa Systeme galenique hydrophobe non ionisable
ITUB20153652A1 (it) * 2015-09-16 2017-03-16 Fatro Spa Microsfere contenenti lattoni macrociclici antielminitici
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
BR112021021649A2 (pt) 2019-05-03 2021-12-21 Intervet Int Bv Composições farmacêuticas injetáveis e usos das mesmas
ES2969653T3 (es) 2020-05-20 2024-05-21 Intervet Int Bv Composiciones farmacéuticas inyectables y usos de las mismas
WO2024003291A1 (en) 2022-06-30 2024-01-04 Virbac Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
DE69208765T2 (de) * 1991-07-23 1996-09-26 American Cyanamid Co Stabile Zusammensetzungen für parenterale Verabrechung und ihre Verwendung
GB2310801A (en) * 1996-03-04 1997-09-10 Merck & Co Inc Process for removing an organic solvent from lactide-glycoside copolymer microspheres

Also Published As

Publication number Publication date
EP1197207A3 (en) 2003-02-05
EP1197207B1 (en) 2008-04-23
CA2358361A1 (en) 2002-04-10
CA2358361C (en) 2009-08-11
DE60133706T2 (de) 2009-07-02
JP2002161033A (ja) 2002-06-04
EP1197207A2 (en) 2002-04-17
DE60133706D1 (de) 2008-06-05
DK1197207T3 (da) 2008-08-04
ATE392887T1 (de) 2008-05-15
AU7827301A (en) 2002-04-11
ES2304371T3 (es) 2008-10-16
AU784023B2 (en) 2006-01-19
JP4221170B2 (ja) 2009-02-12
CY1108145T1 (el) 2013-03-13

Similar Documents

Publication Publication Date Title
IL102567A0 (en) Stable compositions for parenteral administration and their use
CY1108145T1 (el) Σταθερες συνθεσεις για παρεντερικη χορηγηση
DK1087960T3 (da) Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
DK0388019T3 (da) Avermectin-ketal-derivater, der er egnede som antiparasitiske midler
YU23599A (sh) Stabilizovani antihistaminski sirup
HUP0000979A1 (hu) FK-506 jelű vegyületet és származékait tartalmazó gyógyászati készítmények
DK1207756T3 (da) Anvendelse af spinosad eller en formulering, der omfatter spinosad
IL117226A (en) Compositions for controlling parasites and process for preparation thereof
BRPI0406875A (pt) Derivados de monossacarìdeo de avermectina tendo propriedades pesticidas
AP2004003106A0 (en) Synergistic insecticidal mixtures.
DE69331007D1 (de) Difluoroavermectin-derivate
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
WO2004072037A8 (en) 2,3'-bipyridines derivatives as selective cox-2 inhibitors
ES2080175T3 (es) Estabilizador para una preparacion que contiene 4-etil-2-hidroxiimino-5-nitro-3-hexenamida y metodo de estabilizacion correspondiente.
WO2005027903A8 (en) Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors